Evidence map›Paper›PMID 41642435›Full record

ReviewJournal of endocrinological investigation2026

Endocrine late-effects in survivors of childhood and adolescence cancer: clinical management.

Eleonora Biasin, Francesco Felicetti, Alessandro Cattoni, Giuseppina Aloj, Giovanna Giorgiani, Chiara Gorio, Riccardo Haupt, Angela Mastronuzzi, Monica Muraca, Marta Pillon and 2 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Eleonora Biasin *Pediatric Onco-hematology, Ospedale Infantile Regina Margherita, Torino, Italy.
Francesco Felicetti *Oncological Endocrinology, Department of Oncology, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.
Alessandro CattoniPediatric Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Giuseppina AlojDepartment of Oncology, Hematology and Cellular Therapies-Santobono Pausilipon Children's Hospital, Naples, Italy.
Giovanna GiorgianiEmatologia 2-Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Chiara GorioPediatric Onco-Hematology Unit, Children's Hospital; ASST-Spedali Civili, Brescia, Italy.
Riccardo HauptDOPO Clinic, Division of Pediatric Hematology and Oncology, IRCCS Istituto G: Gaslini, Genoa, Italy.
Angela MastronuzziDepartment of Onco-Hematology, Gene Therapy, Cell Therapies and Hemopoietic Transplant, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Monica MuracaDOPO Clinic, Division of Pediatric Hematology and Oncology, IRCCS Istituto G: Gaslini, Genoa, Italy.
Marta PillonMaternal and Child Health Department, Pediatric Hematology Oncology and Stem Cell Trasplant Center, University of Padova, Padova, Italy.
Monica TerenzianiPediatric Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venenzian 1, Milano, 20133, Italy. monica.terenziani@istitutotumori.mi.it.ORCID http://orcid.org/0000-0002-7080-6718
on the behalf of the AIEOP Late Effects Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five-year survival rates after childhood cancer have improved in recent decades: despite these promising survival rates, survivorship is associated with a lifelong increased risk of morbidity and mortality due to late effects of cancer and its treatments. Numerous studies have elucidated the long-term health consequences, and endocrine disorders are identified as among the most prevalent ones, impacting over 40% of this population of survivors. Notwithstanding these findings, many healthcare providers remain unaware of the specific endocrinological recommendations and follow up needs of childhood cancer survivors, with the risk of inadequate monitoring and worsening health issues. This manuscript firstly aims to address the late endocrine complications and we would like to present the Italian experience in developing survivorship care model: by sharing these insights, we hope to enhance understanding and improve care strategies for managing the long-term endocrine health of childhood cancer survivors.

Indexed as

Cancer SurvivorsEndocrine System DiseasesNeoplasmsAdolescentChildHumansChildhood cancer survivorsEndocrine disordersEndocrinological recommendationsSurvivorship care model

Identifiers

PMID41642435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.